Gerard Baquer
Impact in
- Genetics top 5%
- Glioma Diagnosis and Treatment
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
Papers in
- Genetics 7
- Glioma Diagnosis and Treatment 7
-
- Mass Spectrometry Techniques and Applications 7
- Co-authors
- María García‐Altares (5 shared papers)Pere Ràfols (5 shared papers)Xavier Correig (5 shared papers)Michael Scott Regan (5 shared papers)Sylwia A. Stopka (5 shared papers)Nathalie Y.R. Agar (6 shared papers)Juan Ramón Martínez‐François (2 shared papers)Elisa M. York (2 shared papers)
- Journals
- Analytical Chemistry (3 papers)Nature Communications (2 papers)Journal of Cheminformatics (2 papers)Clinical Cancer Research (2 papers)Science Translational Medicine (1 paper)
- Partner nations
- United StatesSpainGermany
In The Last Decade
Gerard Baquer
22 papers receiving 669 citations
Gerard Baquer's Hit Papers
Peers
Comparison fields: 5 of 69
- Genetics 188
- Cancer Research 123
- Spectroscopy 118
- Oncology 107
- Physiology 17
Countries citing papers authored by Gerard Baquer
This map shows the geographic impact of Gerard Baquer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerard Baquer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerard Baquer more than expected).
Fields of papers citing papers by Gerard Baquer
This network shows the impact of papers produced by Gerard Baquer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerard Baquer. The network helps show where Gerard Baquer may publish in the future.
Co-authors
The 25 scholars most cited alongside Gerard Baquer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Oncometabolite d -2HG alters T cell metabolism to impair CD8 + T cell function Hit paper breakdown → | 2022 | 225 |
| 2 | Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways Hit paper breakdown → | 2023 | 114 |
| 3 | 2022 | 71 | |
| 4 | 2022 | 46 | |
| 5 | 2022 | 32 | |
| 6 | 2023 | 31 | |
| 7 | 2021 | 23 | |
| 8 | 2022 | 21 | |
| 9 | 2025 | 18 | |
| 10 | 2023 | 13 | |
| 11 | 2023 | 12 | |
| 12 | 2023 | 11 | |
| 13 | 2025 | 10 | |
| 14 | 2024 | 9 | |
| 15 | 2025 | 9 | |
| 16 | 2020 | 8 | |
| 17 | 2025 | 8 | |
| 18 | 2025 | 5 | |
| 19 | 2023 | 4 | |
| 20 | 2026 | 3 |
About Gerard Baquer
Gerard Baquer is a scholar working on Genetics, Spectroscopy, Cancer Research, Immunology and Cellular and Molecular Neuroscience, having authored 22 papers that have together received 676 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (7 papers), Mass Spectrometry Techniques and Applications (7 papers), Cancer, Hypoxia, and Metabolism (3 papers), Immune cells in cancer (2 papers), Metabolomics and Mass Spectrometry Studies (2 papers), Neuroscience and Neuropharmacology Research (2 papers), Lung Cancer Treatments and Mutations (1 paper) and Cancer Immunotherapy and Biomarkers (1 paper). The work is most often cited by research in Genetics (188 citations), Cancer Research (123 citations), Spectroscopy (118 citations), Oncology (107 citations) and Physiology (17 citations). Gerard Baquer has collaborated with scholars based in United States, Spain and Germany. Frequent co-authors include María García‐Altares, Pere Ràfols, Xavier Correig, Michael Scott Regan, Sylwia A. Stopka, Nathalie Y.R. Agar, Juan Ramón Martínez‐François, Elisa M. York, Anne Miller and Gary Yellen. Their work appears in journals such as Analytical Chemistry, Nature Communications, Journal of Cheminformatics, Clinical Cancer Research and Science Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.